# Ketamine infiltration decreases the need for opioids after thyroid surgery

**Authors:** Moncef Sellami, Imen Zouche, Mariam Ben Ayed, Maroua Bouhali, Khadija Ben Ayed, Salma Ktata, Boutheina Hammami, Mohamed Amine Chaabouni, Ilhem Charfeddine, Mohamed Kahloul, Moncef Sellami, Chihebeddine Romdhani, Widd Kaabi, Moncef Sellami

PMC · DOI: 10.12688/f1000research.127562.1 · F1000Research · 2023-02-23

## TL;DR

Injecting ketamine at the surgical site after thyroid surgery reduces the need for opioids and postoperative pain.

## Contribution

This study demonstrates that ketamine wound infiltration reduces opioid use and pain after thyroid surgery.

## Key findings

- Ketamine infiltration significantly lowered pain scores during the first 24 hours post-surgery.
- Patients receiving ketamine had zero morphine consumption in the PACU compared to 0.71 mg in the placebo group.
- Pain during swallowing was significantly reduced in the ketamine group in the PACU.

## Abstract

Background: Postoperative pain increases the risk of postoperative complications and may predispose patients to chronic post-surgical pain. This study aims to evaluate the impact of ketamine wound infiltration versus placebo at the end of thyroid surgery on postoperative pain and analgesic requirements.

Methods: In this randomized controlled trial, we prospectively studied patients who underwent thyroid surgery. Patients were randomized into two groups: group S, where local infiltration was performed using 10 ml of a physiological saline solution; and group K, where 10 ml of a solution containing 2 mg/kg ketamine was infiltrated. Standardized thyroidectomies were performed in the 2 groups. Pain perception was measured using a visual analog scale (VAS) every 10 minutes in the post-anesthetic care unit (PACU) for 2 hours and thereafter every 6 hours during the first 24 hours. The opioid requirement in the PACU was evaluated. A comparison between the 2 groups was carried out.

Results: Postoperatively, the mean VAS was higher in group S compared to group K during all PACU stay periods and the first 24 hours. Pain scores during swallowing were significantly lower for group K in the PACU at 0, 10, and 20 minutes. The mean morphine consumption in the PACU was 0.71 mg and 0 mg respectively in group S and group K (p=0.03). The incidence of nausea and vomiting was similar in both groups.

Conclusions: Ketamine wound infiltration is an efficient modality to reduce postoperative opioid consumption compared to a placebo after thyroid surgery.

## Linked entities

- **Chemicals:** ketamine (PubChem CID 3821), morphine (PubChem CID 5288826)

## Full-text entities

- **Diseases:** postoperative complications (MESH:D011183), thyroid surgery (MESH:D013966), Pain (MESH:D010146), Postoperative pain (MESH:D010149), nausea and vomiting (MESH:D020250)
- **Chemicals:** Ketamine (MESH:D007649), morphine (MESH:D009020)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10835105/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC10835105/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC10835105/full.md

---
Source: https://tomesphere.com/paper/PMC10835105